SPIE, the international society for optics and photonics, has proudly introduced its latest Gold Open Access journal, Biophotonics Discovery (BIOS). The journal is scheduled to welcome submissions later this year, with the inaugural issue anticipated for publication in early 2024.
The launch of Biophotonics Discovery by SPIE is a strategic move to provide a peer-reviewed platform for the extensive and pioneering research presented annually at the Photonics West BiOS Symposium. This novel journal will serve as a complement to SPIE's existing biomedical journals, such as the Journal of Biomedical Optics (JBO), primarily dedicated to optical-device development, the Journal of Medical Imaging (JMI), and Neurophotonics. Notably, Biophotonics Discovery will encompass the entire spectrum of topics covered at the BiOS symposium, including the more application-specific conferences, which previously lacked a clear peer-reviewed journal outlet within SPIE.
Heading the helm of Biophotonics Discovery is Editor-in-Chief Darren Roblyer, an associate professor of biomedical engineering at Boston University, holding an affiliate appointment in electrical and computer engineering. Roblyer's research is centered on translational diffuse optical imaging and spectroscopy, encompassing the development of wearables, remote patient monitoring technologies, and custom frequency-domain near-infrared spectroscopy techniques to address unmet clinical needs in areas like cancer, cardiovascular disease, kidney disease, and autoimmune diseases. Roblyer collaborates with a diverse array of professionals, including physicians, physiologists, biologists, engineers, and physicists. He has earned several prestigious awards for his work, including the Department of Defense's Era of Hope Scholar Award for breast cancer research and the NIH Trailblazer Award.
Biophotonics Discovery will feature an editorial board appointed by Roblyer, comprising distinguished leaders and emerging researchers in the field of biophotonics.
To further promote accessibility, open access fees will be waived for all submissions to the journal through 2024. Biophotonics Discovery will be published in the SPIE Digital Library, home to the world's most extensive collection of applied research in optics and photonics, comprising over 590,000 publications.
Click here to read the original press release.
